Why the study?
Does recombinant adeno-associated virus vector (rAAV) achieve long-term gene transduction in muscle tissue of immunocompetent mice?
Population
Immunocompetent mice
Design
Preclinical
Follow-up
more than 1.5 years
Authors
Loading...
Supports durable rAAV muscle transduction in mice; leaves open human translation and clinical trials.
Does recombinant adeno-associated virus vector (rAAV) achieve long-term gene transduction in muscle tissue of immunocompetent mice?
Recombinant adeno-associated virus vectors can establish efficient, long-term gene transduction in mammalian muscle cells in vivo without requiring immune modulation.
Xiao et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: